Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
32.98
-0.97 (-2.86%)
Dec 8, 2025, 4:00 PM EST - Market closed
Claritev Market Cap
Claritev has a market cap or net worth of $545.02 million as of December 8, 2025. Its market cap has increased by 422.53% in one year.
Market Cap
545.02M
Enterprise Value
5.17B
1-Year Change
422.53%
Ranking
Category
Stock Price
$32.98
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $545.02M, an increase of 124.29%. That is a compound annual growth rate of 15.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 545.02M | 128.03% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |